Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Thorac Oncol. 2016 Jul 13;11(12):2120–2128. doi: 10.1016/j.jtho.2016.07.002

Table 1.

Demographics and Clinical Characteristics of NLST Cohort Cases

Characteristic Lung Cancer Cases (N = 170) Nodule-Positive Controls (N = 328) P-value1
Age, mean (SD) 63.7 (5.11) 63.5 (5.1) 0.66
Sex, N (%)
 Male 94 (55.3) 192 (58.5)
 Female 76 (44.7) 136 (41.5) 0.28
Race, N (%)
 White 161 (94.7) 315 (96.0)
 Black, Asian, Other 9 (5.3) 13 (4.0) 0.49
Ethnicity, N (%)
 Hispanic or Latino 0 (0.0) 2 (0.6)
 Neither Hispanic/Latino and 170 (100.0) 326 (99.4) 0.55
 Unknown
Smoking, N (%)
 Current 89 (53.4) 175 (53.4)
 Former 81 (47.6) 153 (46.6) 0.85
Pack-Years Smoked, mean (SD)
 Current smokers 63.2 (25.8) 62.0 (21.3) 0.69
 Former smokers 64.5 (27.6) 63.7 (26.8) 0.83
Self-Reported History of COPD, N (%)
 Yes 13 (7.6) 19 (5.8)
 No 157 (92.4) 309 (94.2) 0.44
FH of Lung Cancer, N (%)
 Yes 41 (24.1) 56 (17.1)
 No 129 (75.9) 272 (82.9) 0.07
Stage, N (%)
 I 117 (68.8) --
 II 12 (7.1) --
 III 21 (12.3) --
 IV 18 (10.6) --
 Carcinoid, Unknown 2 (1.2) -- --
Histology, N (%)
 Adenocarcinoma 108 (63.5) --
 Squamous cell carcinoma 38 (22.4) --
 Other, NOS, Unknown 24 (14.1) -- --

Abbreviations: COPD = chronic obstructive pulmonary disease; FH = Family history;

1

P-values calculated using Fisher’s exact test for categorical variables, Student’s t-test for continuous variables